LGND - Ligand Pharmaceuticals Q3 2023 Earnings Preview
2023-11-07 12:10:02 ET
More on Ligand Pharmaceuticals
- Ligand: Nothing Exciting Stands Out
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Ligand Pharmaceuticals closes acquisition of assets of Novan
- Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals
- Historical earnings data for Ligand Pharmaceuticals
For further details see:
Ligand Pharmaceuticals Q3 2023 Earnings Preview